8 November 2017, Geneva – Non-profit research and development organization the Global Antibiotic Research and Development Partnership (GARDP) and the Drugs for Neglected Diseases initiative (DNDi) … GARDP and DNDi launch new South Africa liaison office, hosted by South African Medical Research Council
[Deutsch] BERLIN– Germany together with a number of countries and foundations today pledged EUR 56.5 million to help develop new treatments to fight against antibiotic … 56 million euros raised to fund initiative to fight antibiotic resistance
[Français] GENEVA – Data from 77 countries shows that antibiotic resistance is making gonorrhoea, a common sexually-transmitted infection, much harder, and sometimes impossible, to treat. … Antibiotic resistant gonorrhoea on the rise; need for new drugs
GENEVA AND BOSTON – Entasis and GARDP will co-develop the first-in-class antibiotic, zoliflodacin, in a global Phase III clinical trial to be carried out in … Entasis Therapeutics and the Global Antibiotic Research & Development Partnership to develop a new treatment for gonorrhea